Esperas Pharma Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of LY2880070 in Participants With Advanced or Metastatic Cancer (NCT02632448) | Esperas Pharma Inc. | 2016-05-16 |
Track Esperas Pharma Inc. automatically
Every clearance here is in the API, with alerts when new ones post.